# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA1677702 | Functional | Antiviral activity against Japanese encephalitis virus RP-9 infected in C57BL/6 mouse assessed as mouse survival rate at 1 ug, ip administered one day before and 1 day after viral infection measured after 25 days post infection relative to solvent treated control | Japanese encephalitis virus | 4 | ALA1671729 | organism-based format | Scientific Literature | |
2. | ALA1677703 | Functional | Antiviral activity against Japanese encephalitis virus RP-9 infected in Stat-1-knockout immunodeficient C57BL/6 mouse assessed as mouse survival rate at 1 ug, ip administered one day before and 1 day after viral infection measured after 25 days post infection relative to solvent treated control | Japanese encephalitis virus | 2 | ALA1671729 | organism-based format | Scientific Literature | |
3. | ALA1677704 | Functional | Antiviral activity against Japanese encephalitis virus RP-9 infected in Ig-mu chain-knockout immunodeficient C57BL/6 mouse assessed as mouse survival rate at 1 ug, ip administered one day before and 1 day after viral infection measured after 25 days post infection relative to solvent treated control | Japanese encephalitis virus | 2 | ALA1671729 | organism-based format | Scientific Literature | |
4. | ALA1677705 | Functional | Antiviral activity against Japanese encephalitis virus RP-9 infected in CD8-alpha chain-knockout immunodeficient C57BL/6 mouse assessed as mouse survival rate at 1 ug, ip administered one day before and 1 day after viral infection measured after 25 days post infection relative to solvent treated control | Japanese encephalitis virus | 1 | ALA1671729 | organism-based format | Scientific Literature | |
5. | ALA1677706 | Functional | Antiviral activity against Japanese encephalitis virus RP-9 infected in C57BL/6 mouse assessed as mouse survival rate at 1 ug, ip administered one day before viral infection measured after 25 days post infection relative to solvent treated control | Japanese encephalitis virus | 2 | ALA1671729 | organism-based format | Scientific Literature | |
6. | ALA1677707 | Functional | Antiviral activity against Japanese encephalitis virus RP-9 infected in C57BL/6 mouse assessed as mouse survival rate at 1 ug, ip administered simultaneously with viral infection measured after 25 days post infection relative to solvent treated control | Japanese encephalitis virus | 2 | ALA1671729 | organism-based format | Scientific Literature | |
7. | ALA1677708 | Functional | Antiviral activity against Japanese encephalitis virus RP-9 infected in C57BL/6 mouse assessed as mouse survival rate at 1 ug, ip administered one day after viral infection measured after 25 days post infection relative to solvent treated control | Japanese encephalitis virus | 2 | ALA1671729 | organism-based format | Scientific Literature | |
8. | ALA1677710 | Functional | Antibacterial activity against Sphingomonas capsulata ATCC 14666 infected in C57BL/6 mouse assessed as reduction in lung bacterial load at 50 ug/kg, ip administered 2 hrs post infection measured 24 hrs post infection | Novosphingobium capsulatum | 3 | ALA1671729 | organism-based format | Scientific Literature | |
9. | ALA1677711 | Functional | Antibacterial activity against luminescent Staphylococcus aureus Xen29 infected in BALB/c mouse deep thigh wound infection model assessed as reduction in bacterial load at 150 ug/kg, ip administered 3 hrs post infection by iVIS in-vivo imaging system | Staphylococcus aureus | 3 | ALA1671729 | organism-based format | Scientific Literature |